DICLECTIN TABLET (DELAYED-RELEASE) Canada - English - Health Canada

diclectin tablet (delayed-release)

duchesnay inc - doxylamine succinate; pyridoxine hydrochloride - tablet (delayed-release) - 10mg; 10mg - doxylamine succinate 10mg; pyridoxine hydrochloride 10mg - antihistamines

PMS-DOXYLAMINE-PYRIDOXINE TABLET (DELAYED-RELEASE) Canada - English - Health Canada

pms-doxylamine-pyridoxine tablet (delayed-release)

pharmascience inc - doxylamine succinate; pyridoxine hydrochloride - tablet (delayed-release) - 10mg; 10mg - doxylamine succinate 10mg; pyridoxine hydrochloride 10mg - miscellaneous antiemetics

APO-DOXYLAMINE/B6 TABLET (DELAYED-RELEASE) Canada - English - Health Canada

apo-doxylamine/b6 tablet (delayed-release)

apotex inc - doxylamine succinate; pyridoxine hydrochloride - tablet (delayed-release) - 10mg; 10mg - doxylamine succinate 10mg; pyridoxine hydrochloride 10mg - miscellaneous antiemetics

CARVEDILOL- carvedilol tablet, film coated United States - English - NLM (National Library of Medicine)

carvedilol- carvedilol tablet, film coated

sun pharmaceutical industries, inc. - carvedilol (unii: 0k47ul67f2) (carvedilol - unii:0k47ul67f2) - carvedilol 3.125 mg - carvedilol is indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ace inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization  [see  drug interactions (7.4) and clinical studies (14.1)] . carvedilol is indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of ≤40% (with or without symptomatic heart failure) ( see clinical studies [14.2] ). carvedilol is indicated for the management of essential hypertension. ( see clinical studies [14.3, 14.4] ). it can be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics ( see drug interactions [7.2] ). carvedilol is contraindicated in the following conditions: - bronchial asthma or related bronchospastic conditions. deaths from status asthmaticus have been reported follo

VENLAFAXINE tablet United States - English - NLM (National Library of Medicine)

venlafaxine tablet

avera mckennan hospital - venlafaxine hydrochloride (unii: 7d7rx5a8mo) (venlafaxine - unii:grz5rcb1qg) - venlafaxine 25 mg

VENLAFAXINE tablet United States - English - NLM (National Library of Medicine)

venlafaxine tablet

st marys medical park pharmacy - venlafaxine hydrochloride (unii: 7d7rx5a8mo) (venlafaxine - unii:grz5rcb1qg) - venlafaxine 37.5 mg

VENLAFAXINE tablet United States - English - NLM (National Library of Medicine)

venlafaxine tablet

avera mckennan hospital - venlafaxine hydrochloride (unii: 7d7rx5a8mo) (venlafaxine - unii:grz5rcb1qg) - venlafaxine 100 mg

TEVA-DOXYLAMINE/PYRIDOXINE DR TABLET (DELAYED-RELEASE) Canada - English - Health Canada

teva-doxylamine/pyridoxine dr tablet (delayed-release)

teva canada limited - doxylamine succinate; pyridoxine hydrochloride - tablet (delayed-release) - 10mg; 10mg - doxylamine succinate 10mg; pyridoxine hydrochloride 10mg - antihistamines

STAY SAFE BALANCE 1.5% glucose 1.75mmolL calcium peritoneal dialysis solution bag Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

stay safe balance 1.5% glucose 1.75mmoll calcium peritoneal dialysis solution bag

fresenius medical care malaysia sdn bhd - calcium chloride dihydrate ph. eur.; magnesium chloride hexahydrate pheur; glucose monohydrate, ph eur; sodium chloride (nacl); sodium lactate solution (50%) -

STAY SAFE BALANCE  2.3% glucose 1.75 mmolL calcium peritoneal dialysis solution bag Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

stay safe balance 2.3% glucose 1.75 mmoll calcium peritoneal dialysis solution bag

fresenius medical care malaysia sdn bhd - sodium chloride (nacl); calcium chloride dihydrate ph. eur.; magnesium chloride hexahydrate pheur; glucose monohydrate, ph eur; sodium lactate solution (50%) -